Literature DB >> 21288139

Short communication: CD8(+) T cell polyfunctionality profiles in progressive and nonprogressive pediatric HIV type 1 infection.

Christina F Thobakgale1, Hendrik Streeck, Nompumelelo Mkhwanazi, Zenele Mncube, Lungile Maphumulo, Fundisiwe Chonco, Andrew Prendergast, Gareth Tudor-Williams, Bruce D Walker, Philip J R Goulder, Marcus Altfeld, Thumbi Ndung'u.   

Abstract

Pediatric HIV-1 infection is characterized by rapid disease progression and without antiretroviral therapy (ART), more than 50% of infected children die by the age of 2 years. However, a small subset of infected children progresses slowly to disease in the absence of ART. This study aimed to identify functional characteristics of HIV-1-specific T cell responses that distinguish children with rapid and slow disease progression. Fifteen perinatally HIV-infected children (eight rapid and seven slow progressors) were longitudinally studied to monitor T cell polyfunctionality. HIV-1-specific interferon (IFN)-γ(+) CD8(+) T cell responses gradually increased over time but did not differ between slow and rapid progressors. However, polyfunctional HIV-1-specific CD8(+) T cell responses, as assessed by the expression of four functions (IFN-γ, CD107a, TNF-α, MIP-1β), were higher in slow compared to rapid progressors (p=0.05) early in infection, and was associated with slower subsequent disease progression. These data suggest that the quality of the HIV-specific CD8(+) T cell response is associated with the control of disease in children as has been shown in adult infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288139      PMCID: PMC3332389          DOI: 10.1089/AID.2010.0227

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  24 in total

1.  Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects.

Authors:  G M Ortiz; M Wellons; J Brancato; H T Vo; R L Zinn; D E Clarkson; K Van Loon; S Bonhoeffer; G D Miralles; D Montefiori; J A Bartlett; D F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  The functional profile of primary human antiviral CD8+ T cell effector activity is dictated by cognate peptide concentration.

Authors:  Michael R Betts; David A Price; Jason M Brenchley; Karin Loré; F Javier Guenaga; Anna Smed-Sorensen; David R Ambrozak; Stephen A Migueles; Mark Connors; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

3.  Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

Authors:  Photini Kiepiela; Alasdair J Leslie; Isobella Honeyborne; Danni Ramduth; Christina Thobakgale; Senica Chetty; Prinisha Rathnavalu; Corey Moore; Katja J Pfafferott; Louise Hilton; Peter Zimbwa; Sarah Moore; Todd Allen; Christian Brander; Marylyn M Addo; Marcus Altfeld; Ian James; Simon Mallal; Michael Bunce; Linda D Barber; James Szinger; Cheryl Day; Paul Klenerman; James Mullins; Bette Korber; Hoosen M Coovadia; Bruce D Walker; Philip J R Goulder
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

4.  Evolution and transmission of stable CTL escape mutations in HIV infection.

Authors:  P J Goulder; C Brander; Y Tang; C Tremblay; R A Colbert; M M Addo; E S Rosenberg; T Nguyen; R Allen; A Trocha; M Altfeld; S He; M Bunce; R Funkhouser; S I Pelton; S K Burchett; K McIntosh; B T Korber; B D Walker
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

5.  Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants.

Authors:  Barbara L Lohman; Jennifer A Slyker; Barbra A Richardson; Carey Farquhar; Jenniffer M Mabuka; Christopher Crudder; Tao Dong; Elizabeth Obimbo; Dorothy Mbori-Ngacha; Julie Overbaugh; Sarah Rowland-Jones; Grace John-Stewart
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.

Authors:  L A Guay; P Musoke; T Fleming; D Bagenda; M Allen; C Nakabiito; J Sherman; P Bakaki; C Ducar; M Deseyve; L Emel; M Mirochnick; M G Fowler; L Mofenson; P Miotti; K Dransfield; D Bray; F Mmiro; J B Jackson
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

7.  Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda.

Authors:  Heena Brahmbhatt; Godfrey Kigozi; Fred Wabwire-Mangen; David Serwadda; Tom Lutalo; Fred Nalugoda; Nelson Sewankambo; Mohamed Kiduggavu; Maria Wawer; Ronald Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

8.  Hierarchies in cytokine expression profiles for acute and resolving influenza virus-specific CD8+ T cell responses: correlation of cytokine profile and TCR avidity.

Authors:  Nicole L La Gruta; Stephen J Turner; Peter C Doherty
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Authors:  Marie-Louise Newell; Hoosen Coovadia; Marjo Cortina-Borja; Nigel Rollins; Philippe Gaillard; Francois Dabis
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

10.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

View more
  14 in total

1.  A proposal to use iterative, small clinical trials to optimize therapeutic HIV vaccine immunogens to launch therapeutic HIV vaccine development.

Authors:  Stuart Z Shapiro
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

2.  HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity.

Authors:  Matthew S Parsons; Leia Wren; Gamze Isitman; Marjon Navis; Ivan Stratov; Nicole F Bernard; Stephen J Kent
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

3.  Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses.

Authors:  Theodros S Tsegaye; Katherine Butler; Wei Luo; Jessica Radzio; Priya Srinivasan; Sunita Sharma; Rachael D Aubert; Debra L Hanson; Charles Dobard; Jose Gerardo Garcia-Lerma; Walid Heneine; Janet M McNicholl; Ellen N Kersh
Journal:  J Acquir Immune Defic Syndr       Date:  2015-08-01       Impact factor: 3.731

4.  Reduced frequencies of polyfunctional CMV-specific T cell responses in infants with congenital CMV infection.

Authors:  Laura Gibson; Constance M Barysauskas; Margaret McManus; Sheryl Dooley; Daniele Lilleri; Donna Fisher; Tumul Srivastava; Don J Diamond; Katherine Luzuriaga
Journal:  J Clin Immunol       Date:  2015-02-25       Impact factor: 8.317

Review 5.  Mechanism of Viral Suppression among HIV Elite Controllers and Long-Term Nonprogressors in Nigeria and South Africa.

Authors:  Rahaman Ademolu Ahmed; Khalid Olajide Adekoya; Chika Kingsley Onwuamah; Bolanle Olufunmilayo Oboh; Smita Swaminathan Iyer; Ayomide Samuel Oluwatosin; Rosemary Ajuma Audu; Oliver Chukwujekwu Ezechi
Journal:  Viruses       Date:  2022-06-10       Impact factor: 5.818

6.  Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.

Authors:  Pratima Kunwar; Natalie Hawkins; Warren L Dinges; Yi Liu; Erin E Gabriel; David A Swan; Claire E Stevens; Janine Maenza; Ann C Collier; James I Mullins; Tomer Hertz; Xuesong Yu; Helen Horton
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells.

Authors:  Leia Wren; Matthew S Parsons; Gamze Isitman; Robert J Center; Anthony D Kelleher; Ivan Stratov; Nicole F Bernard; Stephen J Kent
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

8.  Preservation of lymphocyte functional fitness in perinatally-infected and treated HIV+ pediatric patients displaying sub-optimal viral control.

Authors:  Aaruni Khanolkar; William J Muller; Bridget M Simpson; Jillian Cerullo; Ruth Williams; Sun Bae Sowers; Kiana Matthews; Sara Mercader; Carole J Hickman; Richard T D'Aquila; Guorong Liu
Journal:  Commun Med (Lond)       Date:  2022-03-04

Review 9.  The impact of differential antiviral immunity in children and adults.

Authors:  Andrew J Prendergast; Paul Klenerman; Philip J R Goulder
Journal:  Nat Rev Immunol       Date:  2012-09       Impact factor: 53.106

10.  Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection.

Authors:  Xuan He; Dan Li; Zhenwu Luo; Hua Liang; Hong Peng; Yangyang Zhao; Nidan Wang; Donghua Liu; Chuan Qin; Qiang Wei; Huimin Yan; Yiming Shao
Journal:  PLoS One       Date:  2013-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.